Reaction
Pelvic Venous Thrombosis reporting signals
As of the last recalculation, Pelvic Venous Thrombosis appears in 1,423 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is DROSPIRENONE AND ETHINYL ESTRADIOL (PRR 223.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Drospirenone And Ethinyl Estradiol | 458 | 223.0 | 225.4 |
| Etonogestrel And Ethinyl Estradiol | 42 | 28.5 | 28.6 |
| Polatuzumab Vedotin | 14 | 21.2 | 21.2 |
| Ibuprofen And Diphenhydramine Citrate | 28 | 17.9 | 17.9 |
| Cefazolin | 10 | 16.1 | 16.2 |
| Posaconazole | 16 | 14.6 | 14.6 |
| Fondaparinux Sodium | 8 | 14.5 | 14.5 |
| Bendamustine Hcl | 15 | 14.3 | 14.3 |
| Meperidine Hydrochloride | 8 | 12.8 | 12.8 |
| Cefazolin Sodium | 10 | 12.2 | 12.2 |
| Heparin Sodium | 9 | 9.6 | 9.6 |
| Gemcitabine | 25 | 9.4 | 9.4 |
| Tofacitinib Citrate | 8 | 9.0 | 9.0 |
| Bleomycin Sulfate | 6 | 8.5 | 8.5 |
| Granisetron Hydrochloride | 6 | 8.4 | 8.4 |
| Granisetron | 6 | 8.4 | 8.4 |
| Gemcitabine Hydrochloride | 28 | 7.9 | 7.9 |
| Rivaroxaban | 102 | 7.6 | 7.6 |
| Alteplase | 6 | 5.9 | 5.9 |
| Irinotecan Hydrochloride | 5 | 5.7 | 5.7 |
| Oxaliplatin | 28 | 5.6 | 5.6 |
| Cetuximab | 11 | 5.2 | 5.2 |
| Romiplostim | 5 | 4.9 | 4.9 |
| Trifluridine And Tipiracil | 3 | 4.1 | 4.1 |
| Emicizumab | 3 | 3.6 | 3.6 |
| Levonorgestrel | 26 | 1.9 | 1.9 |